Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Inspire submits NDA amendment for diquafosol for dry eye

June 3, 2005

First phase I study of OT-551 for cataracts meets all safety and comfort endpoints

May 30, 2005

Alcon receives approvable letter from FDA for Retaane AMD treatment

May 26, 2005

Isis and Pfizer form ophthalmic antisense drug discovery collaboration

May 26, 2005

Macugen approved in Canada and Brazil

May 26, 2005

Favorable results reported for pegaptanib in wet AMD and DME

May 26, 2005

Novel ophthalmic agents disclosed by the University of Michigan

May 25, 2005

Update on the therapeutic benefits of anecortave in AMD

May 25, 2005

Clinical evidence of the benefits of bevacizumab in patients with eye disorders

May 24, 2005

Phase II data support the use of squalamine lactate in AMD

May 23, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...